stars 1 stars 2 stars 3

Machine Bio is a pre-seed radiopharma platform company enabling targeted radium therapy. Radium is a proven alpha emitter, but because of its incompatibility with therapeutically viable chelation, its reach has been limited to bone or locoregional therapies: Xofigo is FDA-approved and Alpha DaRT is in the clinic, but Xofigo only goes where calcium goes and DaRT only goes where you implant it. We are engineering archM, a protein module that captures radium without a chelator so that radium-223 and radium-224 can be delivered to antigen targets. Our model runs on two paths: partners bring targeting molecules and we give those molecules the ability to hold radium, and we develop selected programs of our own.

Machine Bio Questions

David Marash is the Co-Founder, CEO of Machine Bio.

6 people are employed at Machine Bio.

Top Machine Bio Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users